DK608089D0 - ANTIVIRAL AGENT - Google Patents

ANTIVIRAL AGENT

Info

Publication number
DK608089D0
DK608089D0 DK608089A DK608089A DK608089D0 DK 608089 D0 DK608089 D0 DK 608089D0 DK 608089 A DK608089 A DK 608089A DK 608089 A DK608089 A DK 608089A DK 608089 D0 DK608089 D0 DK 608089D0
Authority
DK
Denmark
Prior art keywords
rna
bioparyl
flavopereirine
primers
fragments
Prior art date
Application number
DK608089A
Other languages
Danish (da)
Other versions
DK608089A (en
Inventor
Mirko Beljanski
Original Assignee
Fond Encourag Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Encourag Rech Med filed Critical Fond Encourag Rech Med
Publication of DK608089D0 publication Critical patent/DK608089D0/en
Publication of DK608089A publication Critical patent/DK608089A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A pharmaceutical composition containing: (1) flavopereirine and/or dihydroflavopereirine; (2) one or more compounds selected from the group consisting of naringin, naringenin and/or their esters or salts which are acceptable from a pharmaceutical standpoint; (3) RNA primers or R.L.B. (RNA fragments); (4) bioparyl. Flavopereirine is an alkaloid of the beta-carboline class. R.L.B. are particular fragments of RNA which act as primers for the replication of leucotyte DNA. Bioparyl is obtained from yellow leaves of the Gingko biloba tree by a special process of extraction, hydrolysis and separation. These products in combination are useful for treating patients suffering from viral diseases, especially AIDS.
DK608089A 1988-12-02 1989-12-01 ANTIVIRAL AGENT DK608089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8815845A FR2639830B1 (en) 1988-12-02 1988-12-02 ANTIVIRAL COMPOSITION AND ITS APPLICATIONS

Publications (2)

Publication Number Publication Date
DK608089D0 true DK608089D0 (en) 1989-12-01
DK608089A DK608089A (en) 1990-06-03

Family

ID=9372531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK608089A DK608089A (en) 1988-12-02 1989-12-01 ANTIVIRAL AGENT

Country Status (8)

Country Link
EP (1) EP0373986B1 (en)
JP (1) JPH0737393B2 (en)
AT (1) ATE94072T1 (en)
DE (1) DE68909019T2 (en)
DK (1) DK608089A (en)
ES (1) ES2059803T3 (en)
FR (1) FR2639830B1 (en)
IL (1) IL92523A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02270824A (en) * 1989-04-13 1990-11-05 Snow Brand Milk Prod Co Ltd Reverse transcriptase inhibitor
DE4105570A1 (en) * 1991-02-22 1992-08-27 Helmut Dr Med Scholle USE OF A BACTERIA- AND PROTEIN-FREE FILTRATE
DE4208868A1 (en) * 1992-03-04 1993-09-09 Michaelis Peter Dr Med Use of ginkgolide cpds., esp. ginkgolide B - in treatment of metastatic cancers, to enhance the effect of chemotherapeutic agents
FR2694693B1 (en) * 1992-07-28 1994-10-28 Abrax Bio Labs Sa Pharmaceutical composition based on flavopereirine and its use in a treatment against the HIV virus.
DE4308443C2 (en) * 1993-03-17 1996-09-19 Laves Hans Georg Medicines used to treat retrovirus infections
JP2003504327A (en) * 1999-07-08 2003-02-04 プレンダーガスト、パトリック、ティ． Use of flavones, coumarins and related compounds for the treatment of infectious diseases
KR100417172B1 (en) * 2000-08-04 2004-02-05 주식회사 안지오랩 Angiogenesis inhibitor containing ginkgo biloba extract
EP1786519B1 (en) * 2004-05-19 2012-09-05 Natural Source International Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
CN107501224B (en) * 2017-09-12 2021-01-19 临沂金卓生物科技有限公司 Method for producing flavonoid aglycone by catalyzing and hydrolyzing ginkgo flavone glycoside with zeolite molecular sieve
EP3773582B1 (en) 2018-03-31 2023-10-25 Molecular International Research, Inc. Selective anti-cancer agent effective for prevention and treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450607A2 (en) * 1978-03-13 1980-10-03 Beljanski Mirko Antiviral, anticancer, antitumour flavopereirine compsn. - activity tests for semperverine, serpentine and alstonine are also given
ATE15971T1 (en) * 1981-03-11 1985-10-15 Mirko Beljanski SERPENTIN, ALSTONIN AND SEMPERVIRIN, MEDICATIONS THAT SPECIFICALLY INHIBIT TUMOR AND CANCER CELLS.

Also Published As

Publication number Publication date
DE68909019T2 (en) 1994-03-17
DK608089A (en) 1990-06-03
FR2639830A1 (en) 1990-06-08
FR2639830B1 (en) 1991-03-22
ES2059803T3 (en) 1994-11-16
DE68909019D1 (en) 1993-10-14
JPH0737393B2 (en) 1995-04-26
IL92523A (en) 1994-05-30
ATE94072T1 (en) 1993-09-15
IL92523A0 (en) 1990-08-31
EP0373986B1 (en) 1993-09-08
JPH02184632A (en) 1990-07-19
EP0373986A1 (en) 1990-06-20

Similar Documents

Publication Publication Date Title
ES2070981T3 (en) ACTIVE COMPONENT CONCENTRATES AND NEW ACTIVE COMPONENT COMBINATIONS OF GINKGO BILOBA LEAVES, THEIR PREPARATION METHODS AND PHARMACEUTICAL PRODUCTS CONTAINING ACTIVE COMPONENT CONCENTRATES OR ACTIVE COMPONENT COMBINATIONS.
AU591125B2 (en) Therapeutic nucleosides
PT88930A (en) METHOD FOR THE PREPARATION OF NEW ANALYSES OF NUCLEOSIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU1331588A (en) Method for treatment of alcohol abuse
DZ1227A1 (en) Benzopyran derivatives process for their preparation and drugs containing said derivatives.
ATE233250T1 (en) SACCHARINE DERIVATIVES AS PROTEOLYTIC ENZYMIN HIBITORS
DK608089A (en) ANTIVIRAL AGENT
DE3767839D1 (en) PYRROLIDINAMIDE DERIVATIVES WITH ANTIPROPYLENE OPEPTIDASE EFFECT, COMPOSITIONS THAT INCLUDE, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS THAT CONTAIN.
DE68929388D1 (en) Anticoagulant compound isolated from urine
ES2045182T3 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCESS FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE74768T1 (en) SOLID PHARMACEUTICAL PREPARATION AND PROCESS FOR MAKING THE SAME.
DE3887068D1 (en) 2,2-Dimethylchromene derivatives, process for their preparation and pharmaceutical compositions containing them.
WO1990013281A3 (en) Method of suppressing hiv infection
DE68927055D1 (en) 2 ', 5'-OLIGOADENYLATE DERIVATIVES FOR USE AS A MEDICINAL PRODUCT
ATE102623T1 (en) THEOPHYLLINEMETHYLDITHIOLANE AND THEOPHYLLINEMETHYLDITHIANYL DERIVATIVES, A PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
OA08165A (en) New thiosulfonate derivatives, their preparation process and the pharmaceutical compositions containing them.
DK113789D0 (en) THIOSULPHINIC ACID DERIVATIVES, THEIR USE IN TREATING DISEASE DISEASES AND MEDICINE CONTAINING THESE SUBSTANCES
FR2595697B1 (en) BENZYL-PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
DE3769358D1 (en) 1-ACYL-2,3-DIHYDRO-4 (1H) -QUINOLINONE-4-OXIME DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE PRODUCTS.
PT90169A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING TIMOPENTIN FOR THE TREATMENT OF PATIENTS SUFFERING FROM VIREMIAS PROVOCADO BY HIV
FR2617481B1 (en) NOVEL TETRAHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2544313B1 (en) N-CYCLOALCOYL METHYL-2 OXO-3 DIARYL 5-6 AS TRIAZINES, THEIR MANUFACTURING PROCESS AND THEIR USE AS MEDICINAL PRODUCTS
EP0253650A3 (en) Improvements relating to benzothiophene derivatives
DK0950053T3 (en) New benzoylalkyl, 1,2,3,6-tetrahydropyridine derivatives
PT87821A (en) PROCESS FOR THE PREPARATION OF 10-PROPYL-2,8-BIS (1H-TETRAZOL-5-YL) -4H, 6H-BENZO (1,2-B, 5,4-B) DYPYRAN-4,6-DIONE OF CALCIUM

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment